CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Rothschild & Co Redburn Adjusts Price Target on Biogen to $210 From $190, Maintains Neutral Rating

Neutral
AI Analysis

Summary

Rothschild & Co Redburn increased its price target on Biogen from $190 to $210 while maintaining a Neutral rating.

Importance:2/10
Sentiment:
0.00
analyst_ratingprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 24, 2026 1:36 PM

Read Original